Neuroprosthesis for Paralysis
(LE-IST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate exercise, standing, stepping and/or balance in people with various degrees of paralysis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the neuroprosthesis for paralysis generally safe for humans?
Functional electrical stimulation (FES) has been researched for over 40 years, establishing principles for safe use in neuromuscular applications. It has been used in various systems to restore function in different body parts, and some have become commercial products, indicating a level of safety in humans.12345
How is the IST-16 treatment for paralysis different from other treatments?
The IST-16 treatment, also known as a Functional Electrical Stimulation (FES) system, is unique because it uses electrical currents to stimulate paralyzed muscles, allowing them to function again. This approach is different from other treatments as it involves wearing small electronic devices that patients can control to help them stand, walk, or perform other movements, which is not typically possible with standard therapies for paralysis.24567
What data supports the effectiveness of the treatment IST-16, Advanced Lower Extremity Neuroprostheses, Functional Electrical Stimulation (FES) System for paralysis?
Research shows that Functional Electrical Stimulation (FES) can help paralyzed muscles contract, allowing people with spinal cord injuries to stand and walk short distances. It has been used successfully in patients with different levels of paralysis, improving their ability to perform activities like standing and walking.12567
Who Is on the Research Team?
Ronald J Triolo, Ph.D.
Principal Investigator
Case Western Reserve University
Musa L Audu, Ph.D.
Principal Investigator
Louis Stokes Cleveland VA Medical Center
Are You a Good Fit for This Trial?
This trial is for adults with paralysis due to spinal cord injury or conditions like stroke, who've been affected for over 6 months. They should have some intact nerve function and be able to move their joints normally. People with heart issues, pregnancy, joint contractures, severe lung/kidney/blood circulation problems, uncontrolled seizures or psychological issues, obesity, drug abuse, immune deficiencies or frequent infections can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo surgery for electrode implantation and initial recovery
Post-operative Training
Training in standing, transfers, and advanced mobility skills using the FES system
Home-based Training
Participants engage in home-based training prior to discharge for home use of the system
Follow-up
Participants are monitored for device reliability and technical performance at 6 and 12 months after discharge, and annually thereafter
What Are the Treatments Tested in This Trial?
Interventions
- IST-16
IST-16 is already approved in United States, European Union for the following indications:
- Paralysis
- Spinal Cord Injury
- Muscle Weakness
- Paralysis
- Spinal Cord Injury
- Muscle Weakness
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Western Reserve University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
US Department of Veterans Affairs
Collaborator